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Abstract
Background: Chronic rhinosinusitis (CRS) is a frequent disease with high social impact and multifactorial pathogenesis.
Recently, single nucleotide polymorphisms within the TAS2R38 gene have been implicated as possible contributors to
the complex gene-environment interactions in CRS.
The purpose of this study was to confirm the proposed correlation between TAS2R38 genotype, CRS and related
comorbidities.
Methods: Fifty-three CRS patients and 39 healthy individuals were genotyped at the TAS2R38 locus. CRS patients were
treated by endoscopic sinus surgery and medical therapies and subdivided in CRS with nasal polyps (CRSwNPs) and
CRS without nasal polyps (CRSsNPs). The effect of genotype on CRS and CRS-related comorbidities was assessed.
Results: The distribution of the different genotypes at the TAS2R38 locus was not significantly different between CRS
patients, either with or without nasal polyps, and controls. Besides, no association was found between the different
genotypes at the TAS2R38 locus and CRS-related comorbidities.
Conclusions: No association was found between TAS2R38 alleles or genotypes and CRS, thus questioning its role in
the pathogenesis of CRS.
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Background
Chronic rhinosinusitis (CRS) represents a burden on pa-
tients quality of life (QoL) [1, 2] and on healthcare sys-
tem [3], as a result of a relevant prevalence in the
general population (14–16 % in the United States [4],
10.9 % in Europe [5–7]).
Despite the remarkable efforts invested in the past de-
cades, CRS pathophysiology is far from being completely
elucidated. Currently, CRS is recognized as a multifac-
torial disease [8] arising from the contribution of
different aetiological factors [9], although most of them
are not definitively proven.
Recently, genetic polymorphisms of bitter taste receptors
(T2Rs) have been proposed as contributors to CRS. T2Rs
are metabotropic G protein coupled receptors (GPCR).
When activated, they ultimately determine calcium release
from intracellular deposits and consequent opening of
TRPM5 (Transient Receptor Potential Channel M5), caus-
ing an action potential that triggers taste perception [10,
11]. In particular, T2R38, whose gene is located on chromo-
some 7q, is implicated in taste perception of phenyl-
thiocarbamide (PTC), one of the genetic traits best
characterized for its distribution in human populations
[12]. Interestingly, T2Rs are expressed not only in gustatory
cells but also in many other tissues [13, 14]. T2R38 expres-
sion has been found also in ciliated human sinonasal epi-
thelial cells, where its function appears to be activated
in vitro by acyl-homoserine lactones (AHLs) [15]. AHLs
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are quorum sensing molecules secreted by Gram-negative
bacteria, such as Pseudomonas aeruginosa, involved in the
regulation of gene expression to direct different bacterial
life cycle processes, for instance biofilm production and
pathogenicity [16, 17] Through calcium-dependent path-
ways, T2R38 increases nitric oxide (NO) production and
mucociliary clearance (MCC), thus contributing to the mu-
cosal innate immunity [18, 19]. The activity of the receptor
depends on three common single nucleotide polymor-
phisms (SNPs) within the TAS2R38 gene (A49P, V262A,
I296P) [12, 18]. These SNPs tend to segregate together,
yielding two common and some less frequent haplotypes.
The two more common are the functional allele, charac-
terised by the presence of proline, alanine and valine (PAV)
at aminoacidic positions 49, 262 and 296, respectively [12]
and the non-functional allele, with alanine, valine and iso-
leucine (AVI) at the same positions. The allelic distribution
varies by geographic region and ethnicity, and has been re-
ported to be 49 % PAV, 47 % AVI and 3 % AAV in popula-
tions of European descent [12]. The different aminoacidic
changes in the T2R38 protein determine a different binding
ability to its ligands and a diverse activation of the signal
transduction cascade. However, it is not completely under-
stood which specific polymorphic position (codons 49, 262
or 296) contributes most to the different aspects of T2R38
activity [20, 21]. The above-mentioned common haplotypes
generate the 3 most common genotypes (PAV/PAV, PAV/
AVI, AVI/AVI) whose phenotypes concern the degree of
PTC taste perception (super-taster, intermediate-taster,
non-taster) [12, 21–23].
Recent in vitro investigations demonstrated that the
super-taster genotype (PAV/PAV) has a significantly in-
creased response to pseudomonal quorum-sensing mole-
cules compared with heterozygous (PAV/AVI) or
homozygous non-taster (AVI/AVI) genotypes, resulting
in an increase in both NO production and ciliary beat
frequency [18].
The hypothesis that a PAV/PAV genotype would be
therefore protective against Gram-negative sinonasal in-
fections and related chronic inflammation, was tested in
a small pilot-study by Adappa and collaborators, that
showed a statistically significant paucity of PAV/PAV
compared to the expected distribution (p < 0.043) in a
cohort of CRS patients undergoing primary functional
endoscopic sinus surgery (FESS) after failure of medical
treatment [17]. This result was confirmed by the same
authors in a larger study, [24] and recently refined,
showing that the TAS2R38 genotype predicts the surgi-
cal outcome in nonpolypoid chronic rhinosinusitis [25].
Based on these promising findings, we wished to: [1]
test whether the different genotypes at the TAS2R38
locus were differentially represented within a prospect-
ively selected Italian population of CRS and [2] investi-
gate the possible correlation between TAS2R38 genotype
and CRS related factors (comorbidities, bacterial infec-
tion, number of surgeries).
Methods
Study
A prospective case-control study was carried out on a
total of 92 individuals, comprising 53 cases (CRS) and
39 controls (CTL).
Cases (CRS)
We recruited patients affected by CRS with nasal polyps
(CRSwNP) or without nasal polyps (CRSsNP), as defined
by the European guidelines [6], referring to the out-
patient clinic for routine follow-up. We included any 18
to 75 year-old patient with a history of at least one pre-
vious endoscopic sinus surgery performed in our tertiary
care hospital, after medical treatment failure, with a
minimum 6 months follow-up from the last surgical
procedure.
We excluded any patients belonging to the V class of
Stammberger classification for CRSwNP [26], those af-
fected by primary and secondary immunodeficiency or
with history of sinonasal trauma and loco-regional
radiotherapy.
Information concerning age, sex, ethnicity, phenotype
of CRS, age at first surgery, total number of surgical pro-
cedures, smoke habit, allergies, asthma, ASA sensitivity,
nasal microbiological data and family history of CRS was
collected for the whole cohort. Finally, venous blood
samples were collected from each patient for TAS2R38
genotyping.
Controls (CTL)
We recruited healthy volunteers, matched to patients for
age and sex, among the healthcare staff of our institute
about to undergo routinely hospital employment blood
examination. The same demographic and selected clin-
ical data, as for the cases cohort, were collected. Exclu-
sion criteria consisted of a positive history of asthma,
allergy and acute or recurrent rhinosinusitis. All controls
underwent venous blood collection for TAS2R38 geno-
typing purpose. We adjusted the controls selection for
geographic region and ethnicity in order to minimize the
environmental differences with the cases.
Ethics, consent and permissions
The Varese University Hospital Ethics Committee ap-
proved this study (Protocol approval n. MED/OTO/
2013/1). All participants provided informed consent to
use their samples for research purposes. Research was
carried out in compliance with the Helsinki Declaration.
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DNA extraction
Five millilitres of whole blood were collected from each
participant using Vacutainer tubes containing citric acid
and dextrose as anticoagulant. Two hundred microliters
of whole blood were used for DNA extraction with the
Purelink Genomic DNA Kit (Life Technologies, Milan,
Italy) following manufacturer instructions. Purified DNA
was eluted in 100 μl of Tris-HCl 10 mM, pH 8.0–9.0
and stored at 4 °C. DNA quality and concentration were
checked by a Nanodrop 2000c spectrophotometer
(Thermoscientific, Milan, Italy) and by agarose gel electro-
phoresis. For genotyping, DNAs were diluted in Polymer-
ase Chain Reaction (PCR) grade water at 10 ng/μl and
checked again by agarose gel electrophoresis to ensure
that equal amounts were used in the analysis.
Genotyping
The genotype at the TAS2R38 locus was determined by
allelic discrimination using the TaqMan 5’-nuclease as-
says (TaqMan SNP Genotyping Assays; Applied Biosys-
tems, Milan, Italy), on a CFX96 platform (Biorad, Milan,
Italy). The following SNPs were characterized: rs713598,
rs1726866 and rs10246939, involving codons 49, 262
and 296, respectively.
Each PCR reaction was performed in 20 μl and con-
tained 10 μl of TaqMan Universal PCR master mix, 1 μl
of TaqMan genotyping assay (pre-diluted to 20x), 1 μl of
genomic DNA diluted at 10 ng/μl and PCR grade water
to volume. Two “No Template Controls” (NTC) were
prepared for each SNP in each plate, to check for ab-
sence of contamination and to orient the graph for ana-
lysis. The amplification program performed an initial
denaturation at 95 °C for 10’, followed by forty cycles of
denaturation at 95 °C for 15” and annealing/extension at
60 °C for 1’. The results of the genotyping were analysed
with the Biorad CFX manager software, version 3.1, and
also manually inspected.
The genotype was scored for each subject.
Statistical analysis
The allele frequencies were determined by direct gene
count method. The observed genotype frequencies were
tested for Hardy-Weinberg equilibrium using the χ2 test,
after applying the Yates correction due to the presence
of rare genotypes. The χ2 test with the Yates correction
was also used to verify the null hypothesis that the likeli-
hood of having CRS depends on the genotype at
TAS2R38 locus, by comparing the differences in allele
frequencies between healthy and diseased individuals.
Statistical analysis was performed using R [27].
Results
Ninety-two individuals were enrolled in the present
study. Thirty-nine were healthy controls and 53 were
patients affected by CRS, subdivided in 36 cases with
nasal polyps (CRSwNP) and 17 without nasal polyps
(CRSsNP).
Upon genotyping, only 6 genotypes were observed in
the whole cohort, derived by the combination of the two
most frequent PAV, AVI alleles and the relatively fre-
quent AAV allele (Table 3). Genotypes derived by other
combinations of rarer alleles were not found in our ana-
lysis. Relevant epidemiological and clinical data as well
as the observed genotypes distribution in CRS and CTL
are reported in Table 1.
Calculation of the expected genotypic frequencies
from the allelic frequencies of the sample allowed us to
demonstrate that our sample population is at the Hardy-
Weinberg equilibrium (χ2 [4] = 3.36; p = 0.499).
Considering the presumed protective role of the PAV
allele towards chronic airway inflammation and infec-
tion, further analyses were performed by clustering
TAS2R38 genotype according to a dosage effect of the
PAV allele, that is the presence of two (PAV/PAV), one
(PAV/-) and no copies (−/−).
A χ2 test of independence was then applied, in order to
investigate whether a particular genotype was related to
CRS phenotype. For this test we subdivided the CRS pa-
tients into those with and without nasal polyps (CRSwNP
and CRSsNP, respectively). No difference in genotypic dis-
tribution was found (χ2 [4] = 2.323, p = 0.677), strongly
suggesting a lack of association between any observed
genotype and CRS (Table 2).
Association between genotype at the TAS2R38 locus and
other CRS related factors was analysed as well, as reported
in Table 3. Again, no significant association was found
(asthma: χ2 [2] = 1.682; p = 0.431; allergy: χ
2
[2] = 1.241;
p = 0.538; ASA sensitivity: χ2 [2] = 2.234; p = 0.327; num-
ber of surgeries: χ2 [2] = 1.030; p = 0.598).
Given the proposed role of T2R38 in innate immune
defence, we also tested whether a specific genotype was
associated with an increased risk of sinonasal bacterial
infection. However, no significant association was found
(χ2 [3] = 0.998, p = 0.910) (Table 4).
Discussion
A genetic basis for CRS has been postulated long ago.
Several pieces of evidence strongly suggest the existence
of a genetic component in CRS, for example the associ-
ation between nasal polyposis and cystic fibrosis, a famil-
iar heritability up to 42 % [28] and a concordance in the
development of sinusitis in identical twins. This
prompted the search for genes contributing to CRS sus-
ceptibility. A large majority of studies focused on the
identification of polymorphisms in genes related to in-
nate immune defence or in regulatory elements of CRS
inflammatory cascade.
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However, despite a conspicuous amount of literature
published, the genetic susceptibility factors to CRS re-
mains largely unknown.
Recently, the bitter taste receptor T2R38, expressed on
human sinonasal ciliated epithelial cells, has been pro-
posed to activate in vitro mucosal innate immune de-
fences, by acting as a detector of Gram-negative quorum
sensing molecules (AHLs) and consequently activating
calcium-dependent pathways leading to an increased
NO production and MCC, to protect against airborne
infections [18]. Similarly, T2R38 was shown to be the
long sought receptor for the Gram negative quorum
sensing molecule AHL-12 in neutrophils [14].
T2R38 receptor activity depends on the status at three
common polymorphisms within the TAS2R38 gene. The
functional allele, in its homozygous state (PAV/PAV),
has been proposed to exert a protective effect in re-
sponse to bacterially secreted AHLs, whereas the homo-
zygous AVI/AVI genotype would not defend against
bacterial infections [18].
The first pilot-study by Adappa et al. was conducted
on 28 patients, undergoing primary FESS, who were ge-
notyped for TAS2R38 and followed-up for 6 months
after surgery [17]. Adappa et al. found that 33 % of the
PAV/AVI genotype patients and 44 % of the AVI/AVI
genotype patients required at least 1 additional course of
postoperative antibiotics (interpreted as a persistence or
a relapse of disease), whereas the single patient with
PAV/PAV genotype within the cohort had favourable
outcomes. A significant difference in genotype fre-
quencies was found between their cohort and other
populations described in the literature, although no
conclusions were drawn, given the small number of
cases examined. In a second paper by the same au-
thors [24], a larger group of patients (70, including
the previously reported cases) was analysed in com-
parison to a control population extracted from a re-
search investigation on taste and smell by Mennella
et al. [23]. Results confirmed their previous observa-
tions on a higher frequency of AVI/AVI genotype in
the medically refractory CRS population than in the
comparison sample. Recently, the same authors re-
fined the prognostic value of the PAV/PAV genotype
which appears to predict a favourable outcome after
surgery (in term of QoL) in CRS patients without
nasal polyps [25].
Since T2R38 activity can be measured in a semi-
quantitative manner using a taste test with PTC strips
[29], evidence of an involvement of specific TAS2R38 ge-
notypes in CRS susceptibility or prognosis (favourable
versus poor outcomes) could be exploited to easily iden-
tify patients at risk of difficult-to-treat-sinusitis, without
expensive genotyping tests. All these promising assump-
tions were the reason for the present prospective study.
Table 1 Demographics and clinical data of the examined
population
CTL CRS
Gender, n (male; female) 39 (20; 19) 53 (27; 26)
Age, years (mean ± SD) 46.6 ± 11.9 52.8 ± 14.7
Ethnic group, n (%)
• Caucasian 38 (97.4) 52 (98.1)
• North African 1 (2.6) 1 (1.9)
CRS phenotype
• CRSwNP, n (%) - 36 (67.9)
• CRSsNP, n (%) - 17 (32.1)
Age at first sinus surgery, years
(mean ± SD)
- 42.9 ± 15.6
Endoscopic sinus surgeries under
general anesthesia (mean ± SD)
- 2.4 ± 1.7
History of asthma, n (%) - 30 (56.6)
History of allergy, n (%) - 29 (54.7)
History of ASA sensitivity, n (%) - 12 (22.6)
Smoking (current smoker/ex-smoker/





Family history of CRS/asthma/allergy,
n (%)
14 (35.9) 23 (43.4)
TAS2R38 genotype
• PAV/PAV, n (%) 7 (17.9) 8 (15.1)
• PAV/AVI, n (%) 17 (43.6) 29 (54.7)
• AVI/AVI, n (%) 12 (30.8) 10 (18.9)
• PAV/AAV, n (%) 1 (2.6) 3 (5.7)
• AVI/AAV, n (%) 2 (5.1) 2 (3.8)
• AAV/AAV, n (%) - 1 (1.9)
SD: standard deviation; CRSwNP: chronic rhinosinusitis with nasal polyps;
CRSsNP: chronic rhinosinusitis without nasal polyps; ASA: acetyl-salicylic acid
Table 2 Observed distribution of genotypes at the TAS2R38




PAV/PAV 7 6 2 15
PAV/- 18 22 10 50
−/− 14 8 5 27
Tot. 39 36 17 92
The number of subjects presenting a particular genotype in each category
(CTL, CRS, CRSwNP, CRSsNP) was multiplied by Π in order to calculate the
expected genotypic frequencies
Π represents the fraction of individuals falling in each category on the total of
subjects [Π(CTL) = 0.424 (39/92); Π(CRSwNP) (36/92) = 0.391;
Π(CRSsNP) (17/92) = 0.185]
Association between genotypes at the TAS2R38 locus and CRS was tested by χ2
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Genotyping of our cohort of 92 subjects revealed a geno-
type distribution comparable to the distribution reported in
other larger series published in the literature [23]. Our
genotyping was made for each of the three SNP separately.
Thus, if a subject was heterozygous at two or three of the
SNPs, alternative genotypes might be possible. However,
since other eventual genotypes would be combinations of
rare or extremely rare haplotypes, and rare alleles were
never found in our cohort even in combination with com-
mon ones, heterozygous genotypes were inferred to be
PAV/AVI. The only way to genotype without uncertainties
would be to clone and sequence the single alleles of the
subjects carrying heterozygous genotypes, but this is not
commonly performed for any such study [12, 23].
In our study no significant difference in the distribu-
tion of the three more common genotypes (PAV/PAV,
PAV/AVI, AVI/AVI) did emerge by comparing CRS pa-
tients and healthy controls.
It is true that our cohort shows an overall high preva-
lence of nasal polyps (67.9 %), asthma (56.6 %) and al-
lergy (54.7 %). These clinical aspects often concur with a
CRS phenotype known to be closely associated to eo-
sinophil levels and Th2 cytokine skewing, with higher
risk for refractory disease [6]. However, we found neither
significant differences in genotype distribution between
CRSwNP and CRSsNP (Table 2), nor significant associ-
ation between any CRS related factors and a particular
genotype (Tables 3 and 4). Finally, the demographic and
clinical features of the present cohort do not substan-
tially differ from those deduced by previous reports
(Additional file 1: Table S1), in which TAS2R38 genotype
seemed to play a role in determining CRS clinical out-
comes [24, 25].
This different behaviour can be explained based on the
complexity of the trait studied, which is not probably
under the control of a single genetic factor. The different
genetic makeup of the populations studied in our work
and in those by Adappa and colleagues is therefore to be
considered when drawing inferences about TAS2R38 and
rhinosinusitis. The present work is undoubtedly not ex-
empt from limitations, first of all due to the relatively
small number of individuals included. In light of these
findings, further studies that include many more patients
collected in a prospective manner with long-term follow-
up are necessary to establish a role for TAS2R38 genotype
in CRS pathogenesis and clinical decision-making.
Only one of the TAS2R38 SNPs, namely rs10246939
(I296V), was found to be weakly associated to CRS in a
previous pooling-based genome-wide association study
(pGWAS), with an allele frequency difference in cases
compared to controls ranging between 11.1 and 15.1 %
in two different populations [30]. However, allelotyping,
deriving from a pGWAS, does not provide information
about haplotype frequencies and requires individual
genotyping to counter errors occurring during the esti-
mation from DNA pools.
Furthermore, it is still unclear how heterozygous indi-
viduals (PAV/AVI), who are the most represented in our
and other series [23, 24], should be considered regarding
a potential susceptibility to CRS. This is the reason why
we preferred to maintain 3 genotypic classes (PAV/PAV,
PAV/-, −/−) in our analysis. It has to be borne in mind
that the ancestral role of this gene is probably related to
food choice and protection from ingesting toxic sub-
stances, present in some vegetables, rather than defence
against airways infections, since variation in the bitter
taste perception predates the divergence between
humans and Neanderthals. In fact, a heterozygous P/A
(probably PAV/AVI) Neanderthal individual has been
Table 3 Observed distribution of genotypes at the TAS2R38 locus and CRS comorbidities (asthma, allergy, ASA sensitivity) or number
of endoscopic surgical procedures in CRS patients, used for association analysis
Asthma Allergy ASA sensitivity N. surgeries Tot.
Present Absent Present Absent Present Absent 1 >1
PAV/PAV 6 2 3 5 2 6 4 4 8
PAV/- 18 14 19 13 9 23 10 22 32
−/− 6 7 7 6 1 12 5 8 13
Tot. 30 23 29 24 12 41 19 34 53
The following Π values were used to calculate the expected frequencies of each comorbidity (see Table 2): Π(Absence of asthma) = 23/53 = 0.434; Π(Absence of allergy) =
24/53 = 0.453; Π(Absence of ASA sensitivity) = 41/53 = 0.774; Π(1 surgery) = 19/53 = 0.358
Association between genotypes at the TAS2R38 locus and CRS aggravating factors was then tested by χ2
Table 4 Observed distribution of genotypes at the TAS2R38
locus and presence and type of bacterial infection within the
CRS patients, used for association analysis
Bacterial infection
Absent Present Tot.
Gram + Gram – and mixed flora
PAV/PAV 4 2 2 8
PAV/- 12 6 14 32
−/− 5 3 5 13
Tot. 21 11 21 53
The following Π values were used to calculate the expected frequencies of
each comorbidity (see Table 2): Π(Absence of bacterial infection) = 21/53 = 0.396;
Π(Presence of Gram +) = 11/53 = 0.453; Π(Presence of Gram – and mixed flora) = 21/53 = 0.396
Association between genotypes at the TAS2R38 locus and bacterial infection
was then tested by χ2
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found [31]. The maintenance of different alleles thus ap-
pears to be an effect of balancing selection at the
TAS2R38 locus. In vitro, T2R38 activation following
AHLs exposure appears to be absent in both AVI/AVI
homozygous and PAV/AVI heterozygous cells [18], al-
though response to the classical ligand, PTC, highlights
a difference between AVI/AVI and PAV/AVI individuals:
the latter can taste PTC strips albeit with high inter-
individual variability.
Additionally, it should not be forgotten that T2R38 ac-
tivity has been tested only in vitro and with Gram-
negative bacteria molecules (AHLs), although the micro-
bial community of CRS is known to include a much
wider range of bacterial and fungal species [32].
Conclusions
In conclusion, in the present study we did not find an
association between TAS2R38 genotype and CRS, thus
questioning its real contribution to CRS susceptibility. It
is also fair to say that, even if no association was found,
we cannot rule out that there might be downstream
mechanisms, regarding for example gene expression
regulation, which may positively or negatively influence
T2R38 functionality. Further studies on larger cohorts
are needed to verify these findings also in vivo and to
shed light on the role of bitter taste receptors in CRS.
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